Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer
BACKGROUND: Relatives of BRCA1 and BRCA2 mutation carriers have long been proposed by epidemiological studies to have an increased risk of developing prostate cancer. In the Ashkenazi Jewish (AJ) population, the existence of 3 frequent founder mutations, 185delAG and 5382insC in BRCA1 and 6174delT i...
Bewaard in:
| Gepubliceerd in: | BMC Med Genet |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMC
2003
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC194219/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12911837/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-2350-4-7 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|